DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Buphenyl (Sodium Phenylbutyrate) - Current Clinical Trials

 
 



Buphenyl Related Clinical Trials

Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 [Not yet recruiting]

Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB) [Recruiting]

Phenylbutyrate Therapy for Maple Syrup Urine Disease [Recruiting]

Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder [Recruiting]

Immune Reconstitution in HIV Disease (IREHIV) [Recruiting]

Immune Reconstitution in Tuberculosis Disease [Recruiting]

Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [Completed]

Mechanism of Fatty Acid-Induced Impairment of Glucose-Simulated Insulin Secretion - Effect of Buphenyl [Recruiting]

Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy [Recruiting]

Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) [Active, not recruiting]

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I [Recruiting]

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III [Recruiting]

Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors [Completed]

Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma [Completed]

Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders [Recruiting]

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer [Active, not recruiting]

Study of the Efficacy and Safety of HPN-100, Glyceryl Tri-(4-phenylbutyrate), for the Treatment of Adults With Urea Cycle Disorders (Help UCD) [Recruiting]

Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [Completed]

Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Completed]

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia [Completed]

Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) [Recruiting]

Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System [Active, not recruiting]

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy [Completed]

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Prostate Cancer [Completed]

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Completed]

Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer [Completed]

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment [Completed]

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children 6-17 Years of Age With Urea Cycle Disorders, With a Long-Term Safety Extension [Recruiting]

Phase II Study of Azacitidine and Phenylbutyrate in Patients With Thalassemia Major [Terminated]

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [Completed]

Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders [Completed]

Effect of Endoplasmic Reticulum Stress on Metabolic Function [Recruiting]

Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) [Not yet recruiting]

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs) [Recruiting]

A Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy (HALT-HE) [Recruiting]

A Double-Blind Randomized Crossover Trial to Define the Electrocardiogram Effects of HPN-100 [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014